SCHEMBL29134091

SCHEMBL29134091

C=CC(=O)Oc1ccc(O)cc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.38
TYMS P04818 1/20 0.38
THRB P10828 3/20 0.36
THRA P10827 1/20 0.36
ALDH5A1 P51649 1/20 0.36
ABAT P80404 1/20 0.36
ALDH1A1 P00352 3/20 0.35
BACE1 P56817 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
GRM4 Q14833 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
ABL1 P00519 1/20 0.32
RIN1 Q13671 1/20 0.32
CAPN1 P07384 1/20 0.32
MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3744533 0.84 MAPK1 (0.48) CTSLTYMSTHRBTHRAALDH1A1
SCHEMBL18459324 0.84 TYMS (0.40) CTSLTYMSTHRBTHRAALDH5A1
SCHEMBL27624619 0.82 SERPINE1 (0.41) TYMSTHRBTHRAALDH5A1ABAT
SCHEMBL39880 0.81 ABL1 (0.49) THRBTHRAALDH1A1MEN1KMT2A
SCHEMBL10766945 0.79 MAOB (0.47) TYMSTHRBTHRAALDH5A1ABAT
Acetic Acid SCHEMBL28463886 0.78 ABL1 (0.46) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL9282538 0.77 CFD (0.49) CTSLALDH1A1MEN1KMT2AGAA
SCHEMBL1215245 0.77 THRB (0.49) TYMSTHRBTHRAALDH1A1MEN1
SCHEMBL30596851 0.77 THRB (0.49) TYMSTHRBTHRAALDH1A1MEN1
SCHEMBL27557556 0.76 THRB (0.36) CTSLTYMSTHRBTHRAALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112004816-B PRC2 inhibitors 米拉蒂医疗股份有限公司 2024-01-05 CN disclosed
CN-114269748-A Imidazo [1,2-c ] pyrimidine derivatives as PRC2 inhibitors for the treatment of cancer 米拉蒂医疗股份有限公司 2022-04-01 CN disclosed
CN-112004816-A PRC2 inhibitors 米拉蒂医疗股份有限公司 2020-11-27 CN disclosed